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Abstract
Background: Macrophage foam cell formation is a prominent feature of human atherosclerotic
plaques, usually considered to be correlated to uptake of and inflammatory response to oxidized
low density lipoproteins (OxLDL). However, there are alternative pathways for formation of
macrophage foam cells and the effect of such lipid loading on macrophage function remains to be
fully characterized. In the present study we investigated basal and inducible cytokine expression in
primary human macrophages either loaded with triglycerides through incubation with very low
density lipoproteins (VLDL) or with cholesterol through incubation with aggregated LDL (AgLDL).
We then analyzed how foam cell lipid content affected secretion of three pro-inflammatory
cytokines: interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), and of
one chemokine: interleukin-8 (IL-8), all of which are considered pro-inflammatory, pro-
atherosclerotic, and are expressed by cells in atherosclerotic tissue.
Results: Formation of triglyceride-loaded foam cells resulted in a four-fold increase in basal IL-1β
secretion, whereas cholesterol loading lacked significant effect on IL-1β secretion. In contrast,
secretion of TNF-α and IL-6 decreased significantly following both cholesterol and triglyceride
loading, with a similar trend for secretion of IL-8. Lipid loading did not affect cell viability or
expression of caspase-3, and did not significantly affect macrophage ability to respond to
stimulation with exogenous TNF-α.
Conclusion: Lipid loading of primary human macrophages resulted in altered cytokine secretion
from cells, where effects were similar regardless of neutral lipid composition of cells. The exception
was IL-1β, where triglyceride, but not cholesterol, lipid loading resulted in a stimulation of basal
secretion of the cytokine. It is apparent that macrophage cytokine secretion is affected by lipid
loading by lipoproteins other than OxLDL. As both VLDL and AgLDL have been found in the vessel
wall, macrophage cytokine response to uptake of these lipoproteins may have a direct effect on
atherosclerotic development in vivo. However, macrophage neutral lipid amount and composition
did not affect cellular activation by exogenous TNF-α, making it likely that lipoprotein lipid loading
can affect foam cell cytokine secretion during basal conditions but that the effects can be overruled
by TNF-α during acute inflammation.
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Background
The macrophage foam cell is a prominent feature of all
stages of atherosclerosis, but the effect of foam cell trans-
formation on macrophage functional properties remains
to be fully characterized. A body of evidence has identified
uptake of oxidized low density lipoproteins (OxLDL) as
the major cause of foam cell formation. OxLDL contains
a number of highly pro-inflammatory and cytotoxic sub-
stances making it difficult to differentiate between the
direct effects of these components and the effect of lipid
loading in itself on macrophage function. However, there
are also alternative pathways for formation of macro-
phage foam cells, including uptake of very low density
lipoproteins (VLDL) and aggregated low density lipopro-
teins (AgLDL). It has been demonstrated that VLDL can
penetrate the endothelium [1], and apolipoprotein B-con-
taining lipoprotein particles of VLDL size and density
have been isolated from human atherosclerotic tissue [2].
AgLDL can be prepared in vitro by phospholipase treat-
ment of native LDL or by a simple vortex procedure. It is
believed that LDL aggregation also occurs in vivo, in par-
ticular on the surface of extra cellular matrix components
such as chondroitin sulphate. AgLDL has been found in
atherosclerotic plaques of apolipoprotein E knock out
mice [3] where AgLDL levels positively correlated with
severity of plaque development.
We have previously shown that incubation with VLDL
enhances macrophage interleukin-1β (IL-1β) expression
in a caspase-1 dependent manner [4] and potentiates LPS-
induced expression of TNF-α by stimulation of mitogen-
activated protein kinase-ERK kinase 1/2 (MEK 1/2) sug-
gesting a pro-inflammatory effect of lipid-loading with
triglyceride-rich lipoproteins. In contrast, a reduced
expression of tumor necrosis factor-α (TNF-α) has been
observed in macrophages incubated with acetylated LDL
[5]. These observations suggest that lipid loading may
have a direct effect on macrophage functional properties
and that these effects may differ depending on lipid com-
position of the ingested lipoprotein. The aim of the
present study was to characterize how macrophage lipid
loading affects basal and TNF-α-induced cytokine secre-
tion and if this secretion is influenced by lipid composi-
tion of lipid-loaded cells. By incubating primary human
macrophages with either AgLDL or VLDL we created a
model system for foam cell formation with cholesterol
ester or triglycerides as main component of intracellular
lipid droplets. We then analyzed how foam cell lipid con-
tent affected secretion of three pro-inflammatory
cytokines: IL-1β, IL-6 and TNF-α, and of one chemokine:
IL-8, all of which are expressed by cells in atherosclerotic
plaques [6-9]. IL-1β and TNF-α are involved in macro-
phage activation, and IL-6 can be induced by both IL-1β
and TNF-α and represents secondary response to macro-
phage activation [10]. IL-8 is a chemoattractant for several
cell types present in atherosclerotic tissues, such as T-cells
and smooth muscle cells, and has been reported to trigger
monocyte adhesion to endothelial cells, an early event in
atherosclerosis development [11]. Macrophages isolated
from human atherosclerotic plaques release high levels of
IL-8, and cholesterol loading has been suggested to trigger
macrophage IL-8 production [9]. Our results indicate that
both cholesterol loaded and triglyceride loaded cells have
decreased basal secretion of pro-inflammatory cytokines,
with the exception for IL-1β where basal secretion was
stimulated by triglyceride loading. In contrast, lipid load-
ing did not influence the level of cytokine secretion in
response to stimulation with exogenous TNF-α.
Results
Lipid loading of cells
Human macrophages isolated from 6 different blood
donors were incubated for 16 h in serum-free media with
or without addition of 50 μg/ml of native LDL, AgLDL or
VLDL. The cells were incubated in lipoprotein-free media
for an additional 4 h in order to minimize potential con-
founding effects of extracellular lipoproteins on subse-
quent analysis of cytokine secretion. Incubation with
AgLDL resulted in a two-fold increase of intracellular cho-
lesterol and a modest increase of intracellular triglyceride
levels, while incubation with native LDL only induced a
minor increase in intracellular triglycerides (Fig. 1). Mac-
rophages incubated with VLDL demonstrated a six-fold
increase in triglycerides, with no significant effect on
intracellular cholesterol levels (Fig. 1). The variation in
final cholesterol and triglyceride levels between cells from
different donors was relatively minor. Activation of cells
by addition of 1 ng/ml of TNF-α during the final 4 h of
incubation induced a modest increase in total cholesterol
levels in cells exposed to native LDL, but was otherwise
without effect on intracellular lipid levels (Fig. 1).
Cytokine secretion
Control macrophage secretion of IL-1β, IL-6 and TNF-α
ranged between 4 and 40 pg/mg cell protein, whereas con-
trol macrophage secretion of IL-8 was higher by several
orders of magnitude (Fig. 2). The variability in cytokine
and IL-8 expression between individual donors was
higher than that observed for intracellular lipid content.
As earlier reported by us [4], formation of triglyceride-
loaded foam cells by incubation with VLDL resulted in a
significant increase in IL-1β secretion from the cells. In
contrast to this, macrophage cholesterol loading by incu-
bation with AgLDL had no significant effect on IL-1β
secretion (Fig. 2A). The effect of triglyceride loading on IL-
1β secretion differed markedly from that observed for the
other two cytokines and IL-8; secretion of TNF-α and IL-6
decreased significantly in both triglyceride and cholesterol
loaded cells (Fig 2B and 2C). In addition, IL-8 secretion
was significantly decreased by triglyceride loading withLipids in Health and Disease 2006, 5:17 http://www.lipidworld.com/content/5/1/17
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Intracellular lipid content Figure 1
Intracellular lipid content. Lipid content of cells after 16 h lipoprotein pre-treatment and 4 h conditioning with or without 
exogenous TNF-α (1 ng/ml). (A) Intracellular levels of total cholesterol (free cholesterol and cholesterol ester) normalized to 
cell protein, (B) intracellular triglyceride levels normalized to cell protein. Data represent mean ± SEM of cells from six differ-
ent blood donors. * = P < 0.05, ** = P < 0.01 and *** = P < 0.001 for comparisons of intracellular lipid content of lipoprotein 
treated vs. non-treated cells. Light grey = non-stimulated cells, dark grey = cells stimulated by incubation with TNF-α.
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VLDL, and a similar trend was observed following choles-
terol loading with AgLDL (Fig. 2D). Pre-incubation of
macrophages with LDL decreased basal secretion of TNF-
α, but had no other significant effect on cytokine and IL-
8 secretion (Fig. 2B). Treatment with 1 ng/ml of TNF-α
generally stimulated the secretion of IL-1β, IL-6, and IL-8
in control as well as in lipid loaded cells. Cholesterol
loading did not affect the macrophage ability to respond
to TNF-α stimulation (Fig. 3A–C). Triglyceride-loaded
cells responded to activation by exogenous TNF-α with
stimulated secretion of IL-6 and IL-8 compared to basal
secretion from the same preparations of triglyceride-
loaded cells (Fig 3B and 3C), whereas there was no signif-
icant difference in IL-1β secretion from triglyceride-
loaded cells incubated in absence or presence of exoge-
nous TNF-α (Fig 3A).
Cell viability and apoptosis
Cell viability was controlled by the MTT assay and by
analysis of LDH leakage to incubation media. No treat-
ment induced decreased cell viability as monitored by
these two methods (data not shown). However, it is pos-
sible that the observed cytokine levels in media condi-
tioned with lipid loaded cells are correlated to apoptotic
responses not noticeable by cell viability assays. As our
previous data demonstrated a connection between IL-1β
secretion and a marker for apoptotic development, we
used two independent parameters, caspase-3 activity and
quantification of DNA laddering, to evaluate apoptosis in
the current experiments. Neither apoptotic parameter was
significantly altered in cells treated with native or aggre-
gated lipoproteins, whereas oxidized LDL used as positive
control gave a strong signal with both methods for apop-
tosis evaluation (data not shown).
Discussion
The present results demonstrate that lipid loading had an
inhibitory effect on basal macrophage secretion of some,
but not all, analyzed pro-inflammatory cytokines,
whereas lipid loading did not influence the macrophage
Cytokine secretion during basal conditions Figure 2
Cytokine secretion during basal conditions. Primary human monocytes differentiated for four days were pre-incubated 
for 16 h serum-free media in presence or absence of LDL, AgLDL or VLDL (50 μg/ml). After pre-incubation, fresh media with-
out lipoproteins, serum or growth factors was conditioned for 4 h and analyzed for cytokine protein content by ELISA. (A) 
Secreted IL-1β normalized to cell protein, (B) secreted TNF-α normalized to cell protein, (C) secreted IL-6 normalized to cell 
protein, (D) secreted IL-8 normalized to cell protein. Data represent mean ± SEM of cells from six different blood donors. * = 
P < 0.05, ** = P < 0.01 for respective lipoprotein treatment compared to control.
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Cytokine secretion during stimulated conditions Figure 3
Cytokine secretion during stimulated conditions. Cell were pre-treated for 16 h with or without lipoproteins (50 μg/
ml), then activated by incubation with exogenous TNF-α (1 ng/ml) for 4 h. For each lipoprotein pre-treatment, significances 
indicate comparisons between cells incubated in absence or presence of TNF-α. (A) Secreted IL-1β normalized to cell protein, 
(B) secreted IL-8 normalized to cell protein, (C) secreted IL-6 normalized to cell protein. Data represent mean ± SEM of cells 
from six different blood donors. * = P < 0.05, ** = P < 0.01 and *** = P < 0.001.
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ability to respond to stimulation with exogenous stimuli,
such as TNF-α. Both triglyceride and cholesterol lipid
loading resulted in significantly decreased secretion of the
pro-inflammatory cytokines TNF-α and IL-6 compared to
control cells incubated in absence of lipoproteins. There
was also a trend towards decreased secretion of IL-8. How-
ever, the effect of lipid loading on secretion of IL-1β was
markedly different. Triglyceride loading by incubation
with VLDL was associated with a strong stimulation of
basal IL-1β secretion. It is unlikely that cytokines recov-
ered from conditioned media are the result of cytotoxic
effects of either lipoprotein treatment. First, lipoproteins
were controlled for endotoxins and oxidation products
before used in experiments. Second, neither lipoprotein
lipid loading treatment induced cell death, as judged by
the MTT assay and by LDH leakage to conditioned media
compared to controls.
It has previously been shown that the increased IL-1β
secretion from macrophages exposed to VLDL in part can
be explained by stimulation of post-translational proc-
esses involving activation of caspase-1, the enzyme that
cleaves the IL-1β pro-peptide prior to exocytosis. Expres-
sion of IL-1β and TNF-α are both regulated by the tran-
scription factor NF-κB, and in endothelial cells NF-κB
activity is up-regulated by triglyceride loading induced by
VLDL [12], making up-regulation of NF-κB activity a likely
candidate for the observed effect on IL-1β secretion from
triglyceride loaded cells but an unlikely candidate for reg-
ulation of the other analyzed cyto- and chemokines. It is
also possible that some of the observed effects of lipid
loading were mediated by peroxisome proliferators acti-
vated receptor-γ (PPAR-γ) as this nuclear receptor has
been reported to be up-regulated by oxidized LDL [13]
and PPAR-γ has been reported to negatively regulate
expression of IL-1β, IL-6 and TNF-α [14]. However, during
basal conditions there was no positive correlation
between IL-1β and TNF-α secretion neither in triglyceride-
rich nor in cholesterol-rich cells. In fact, secretion of the
two cytokines appeared to be inversely regulated suggest-
ing involvement of additional regulatory mechanisms.
Pre-incubation of macrophages with LDL significantly
lowered basal secretion of TNF-α but had no significant
effect on macrophage secretion of IL-1β, IL-6, or IL-8,
indicating that either intracellular lipid level needs to
reach a threshold level or signaling events not mediated
through the LDL receptor are required for the panel of
effects on macrophage cytokine secretion that appears to
be induced by triglyceride or cholesterol loading. A full
explanation to why macrophage triglyceride lipid loading
by VLDL uptake, but not cholesterol lipid loading by
uptake of AgLDL, results in opposing effects on IL-1β vs.
IL-6, IL-8 and TNF-α secretion still remains to be eluci-
dated, but it is possible that the earlier reported stimula-
tion of IL-1β release by VLDL stimulation of caspase-1
activity is responsible for this difference.
The observation that macrophage triglyceride loading by
VLDL but not cholesterol loading by AgLDL stimulates
expression of IL-1β is of interest against the background of
epidemiological findings of a strong association between
VLDL and inflammatory makers such as C-reactive pro-
tein (CRP), while no, or only weak, such associations are
found between LDL and inflammatory makers. Hypertrig-
lyceridemia is prevalent in diabetic patients, whereas
hypercholesterolemia is associated both with an increased
risk for LDL oxidation and a high risk for formation of
aggregated LDL in the intimal matrix of the vascular wall.
Oxidized LDL exerts strong effects on macrophage
cytokine signaling – effect usually pinpointed to specific
oxysterols and other lipid oxidation products – and there-
fore the main focus for studies of lipoprotein effects on
macrophage foam cell inflammatory response has been
on oxidized lipoproteins and specific lipid species. Our
present data illustrates that human macrophages respond
to lipid loading induced by non-oxidized lipoproteins
with significant alterations in basal cytokine secretion, an
effect most pronounced in triglyceride-rich but also
induced in cholesterol-rich cells. It is apparent from our
study and others [12] that lipoprotein oxidation is not a
prerequisite for lipoprotein influence on macrophage
immune response. Support for a direct effect of lipid-load-
ing on macrophage function has also come from animal
studies demonstrating decreased expression of the growth
factor PDGF-B in atherosclerotic plaque foam cells as
compared to macrophages with no visible lipids [15].
Conclusion
In conclusion, lipid loading of primary human macro-
phages results in altered cytokine secretion from cells,
where effects were similar regardless of neutral lipid com-
position of cells. The exception was IL-1β, where triglycer-
ide, but not cholesterol, lipid loading resulted in a
stimulation of basal secretion of the cytokine. However, as
exogenous TNF-α did activate both lipid loaded and con-
trol cells regardless of foam cell neutral lipid composition,
and tissue levels of TNF-α are relatively high in atheroscle-
rotic plaques, potentially anti-inflammatory effects of
neutral lipid loading are likely to be of minor importance
in atherosclerotic tissue during active inflammatory
response.
Methods
Lipoprotein preparation
Lipoproteins were prepared by differential ultra centrifu-
gation of fresh plasma from healthy donors [16]. Lipopro-
teins were stored at -80°C with 10% sucrose and 4.8 mM
EDTA, pH = 7.4, a procedure which does not affect lipo-
protein integrity [17]. Lipoproteins were thawed andLipids in Health and Disease 2006, 5:17 http://www.lipidworld.com/content/5/1/17
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desalted immediately before use and protein content
determined with BCA protein assay reagent (Pierce). Lipo-
protein oxidation was determined by the conjugated
diene assay [18]. Lipoprotein fraction integrity was con-
firmed by agarose gel electrophoresis (Sebia, France).
Endotoxin content of lipoprotein preparations were <0.03
EU/ml as determined by the Limulus assay (E-toxate,
Sigma). Aggregated LDL was prepared by vortexing LDL
preparations for 3 min just before use [19]. Oxidized LDL
was prepared by incubation of LDL with 5 μM CuSO4 at
37°C for 48 h.
Cell culture
Primary human monocytes were isolated from buffy coats
from healthy donors [20] and seeded in 6-well plates at a
cell density of 2 × 106 cells/well. Cells were maintained for
4 × 24 hours in basal media: Macrophage-serum free
media (Macrophage-SFM) with transferrin (25 μg/ml),
glutamine (2 mM), gentamicin (50 μg/ml), and granulo-
cyte macrophage-colony stimulating factor (GM-CSF, 10
ng/ml), at 37°C with 5% CO2. After this, media was
changed to basal media without GM-CSF for 24 h, with or
without lipoproteins (50 μg/ml) present for the last 16 h.
Cytotoxic effects of lipoprotein treatments was assessed by
the MTT (methylthiazoletetrazolium) assay (Sigma).
Finally, cells were rinsed and fresh GM-CSF and lipopro-
tein free media with or without exogenous TNF-α (final
concentration 1 ng/ml) was conditioned with treated cells
for 4 hours. Cell viability was assessed by analyzing leak-
age of LDH (lactate dehydrogenase assay, Sigma). Condi-
tioned media were removed, protease inhibitor was added
(PMSF, final concentration 1 mM) and media were centri-
fuged at 1000g for 5 minutes to remove floating cells or
cell debris.
Chemical analyses
Cell lipids were extracted with hexane:isopropanol (3:2 +
0.005% butylhydroxytoluene), dried down under N2 and
reconstituted in ethanol. Lipid analyses (triglycerides and
total cholesterol) were performed with colorimetric assays
(Sigma). After lipid extraction, residual cell proteins were
dissolved in 0.3 M NaOH and cell lysates used for cell pro-
tein analyses with BCA protein reagent (Pierce).
Cytokine analyses
Interleukin-8 (IL-8) and interleukin-1β (IL-1β) were ana-
lyzed by commercial ELISA sets (R&D systems). Inter-
leukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were
analyzed with matched antibodies (Dako, Denmark) in
high-sensitivity sandwich ELISAs developed in the labora-
tory [21].
Apoptosis assessment
Apoptosis was evaluated using two independent methods.
Cells incubated with OxLDL were used as positive con-
trols. Cell lysates after lipoprotein treatment were ana-
lyzed for caspase-3 activity according to manufacturer's
instructions (BD Biosciences). For DNA laddering analy-
sis, cell homogenates in PBS were separated in cytosolic
and nuclear fractions, after which DNA was released from
histones by addition of 5 M NaCl before precipitation
with isopropanol. DNA was rinsed with ice cold ethanol,
pelleted by centrifugation at 20 000g and pellets dissolved
in TE buffer (1 mM EDTA, 10 mM Tris-HCl, pH = 7.4)
before being separated on agarose gels.
Statistical analyses
Experiments were performed using cells isolated from six
different donors, with analyses performed in duplicates
for each donor. All data are reported as mean ± SEM. Sta-
tistical differences are calculated using Mann-Whitney
non-parametric test.
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